Cooperative Agreement HU0001262E074
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $2.8M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
United States
Similar Awards
- DOD Uniformed Services University of the Health Sciences awarded The Geneva Foundation a Cooperative Agreement for $364,715 on July 20, 2026 under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to correlate repetitive blast overpressure exposure with neuroinflammation and microstructural changes assessed by MRI in a large animal model. Performance runs through July 19, 2027 and occurs in the United States. The Geneva Foundation is a 501(c)(3) nonprofit research...
- The Uniformed Services University of the Health Sciences awarded The Geneva Foundation a $2.298 million cooperative agreement on January 1, 2026, under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to support Blood Transfusion Optimization research through December 31, 2028. The award funds research and development activities to optimize blood transfusion protocols and clinical practices for military medical readiness. Work is performed in Westlake,...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
- The Uniformed Services University of the Health Sciences awarded a cooperative agreement to The Geneva Foundation on September 1, 2026, in the amount of $1,176,092, under the Uniformed Services University Medical Research Projects program (CFDA 12.750). The award funds independent verification and validation support for the Defense Advanced Research Projects Agency GOLDEVAC initiative. Performance occurs in Westlake, Maryland, with a period of performance through August 31, 2028. The Uniformed...
- The Uniformed Services University of the Health Sciences awarded The Geneva Foundation a $458,325 cooperative agreement on May 1, 2026, to demonstrate diagnostic devices for concussion in operational medicine environments under the Uniformed Services University Medical Research Projects program (CFDA 12.750). The award funds research and development of diagnostic technology for concussion assessment in military operational settings. Performance runs through April 30, 2028, across the United...
- This Project Grant award in the amount of $325,650.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization based in Tacoma, Washington. The funding supports an assessment of changes in the human blood proteome following total sleep deprivation over a performance period from March 1, 2025 to February 28, 2027. The Geneva Foundation frequently collaborates with subcontractors such...
- The Defense Health Agency awarded The Geneva Foundation $999,766 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to accelerate personalized T-cell receptor immunotherapy for microsatellite-stable colorectal cancer through development of a multimodal prediction model. The project runs through August 31, 2029, with work performed in Tacoma, Washington. This Project Grant is assistance funding supporting biomedical research to transform health care...
- The Uniformed Services University of the Health Sciences awarded a $177,201 cooperative agreement to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on December 1, 2025 under the Uniformed Services University Medical Research Projects program (CFDA 12.750) to support the Sleep, Performance, and Cognition Enhancement (SPACE) Program, which funds sleep restoration to optimize warfighter readiness and performance. The award runs through November 30, 2026 with place of...
- The Defense Health Agency awarded The Geneva Foundation $559,224 on May 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support in vivo selection of prometastatic tumor microbiota in pancreatic cancer. Performance runs through May 14, 2029, at The Geneva Foundation's location in Tacoma, Washington. This is a Project Grant, a form of assistance funding supporting basic, applied, and advanced biomedical research to transform health care for Service Members...
- The Defense Health Agency awarded The Geneva Foundation $4,397,396 for extracorporeal immunomodulation to reduce inflammation after severe burns, inhalation injury, and septicemia under the Military Medical Research and Development program (CFDA 12.420) on November 1, 2025. The award funds research into extracorporeal immunomodulation technology to mitigate the inflammatory cascade and associated organ damage in patients suffering severe thermal injury, smoke inhalation, and septic...